Skin Cancer (Nonmelanoma)

Digital Device Aids Skin Cancer Diagnostics
January 07, 2022

Skin cancer dermoscopy is getting a hightech overhaul as the scope of innovation broadens from a singular focus on the stand-alone product to the development of a comprehensive medical, patient care, and workflow management platform.

Adolescents and Sun: Are They Protected?
November 25, 2021

Skin cancer is on the rise. Knowing what teenagers and adolescents understand about protecting skin from the sun and how well they’re using that information can be important to changing that trend.

Update on Actinic Keratosis Causes and Care Plans
November 14, 2021

Brian Berman, MD, PhD, maps the root causes, prevention strategies, and latest treatments for this widespread precancer at 2021 Fall Clinical Dermatology Conference for PAs & NPs.

Study: New Portable Device for At-Home Skin Cancer Treatment
October 05, 2021

Data from a pilot study on a new prototype photodynamic therapy device for BCC was shown at the EADV Congress.

Master the Clues that Mask Malignancy
October 02, 2021

Case-based observations offered clinicians real-world guidance on distinguishing underlying malignancies in the Therapeutic Hotline session at Maui Derm NP+PA Fall 2021.

SCC and BCC Updates from Maui Derm NP+PA Fall
October 01, 2021

At Maui Derm NP+PA Fall 2021, George Martin, MD, discussed his opinion on best treatment options for SCC in situ and cutaneous SCC at high risk for metastasis along with BCC that require special considerations.

AK Overview: Current Guidelines and Emerging Therapies
September 30, 2021

A review of the American Academy of Dermatology guidelines and current treatment improvements for actinic keratosis were discussed during a presentation at Maui Derm NP+PA Fall 2021.

Gut Microbiome Can Affect Radiation Cancer Treatment
September 16, 2021

The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.

Topical Remetinostat Effective, Tolerable in Basal Cell Carcinoma
September 16, 2021

The topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.

Image-Guided Superficial Radiotherapy for BCC and SCC
September 15, 2021

New study data shows positive data for Image-Guided Superficial Radiotherapy (IGSRT) in treating basal cell carcinoma and squamous cell carcinoma.